Boston Neuro Research is conducting extensive research to develop better treatments for Parkinson’s disease, a progressive disorder of the nervous system that affects movement.

INCLUSIONS:

Participants eligible for the Parkinson’s study must meet the following criteria:

1. Diagnosis: Individuals must have a clinical diagnosis of Parkinson’s disease.
2. Age: Participants should be aged 40 to 80 years.
3. Health Status: Stable medical conditions unrelated to Parkinson’s that do not interfere with study procedures.
4. Caregiver: A reliable caregiver must be available to assist with participation in the study.
5. Informed Consent: Participants and caregivers must provide informed consent to join the study.

EXCLUSIONS:

Factors that may disqualify individuals from the Parkinson’s study include:

1. Advanced Parkinson’s Disease: Individuals with severe symptoms that hinder participation.
2. Other Neurological Disorders: Presence of significant neurological disorders other than Parkinson’s.
3. Unstable Medical Conditions: Uncontrolled chronic illnesses such as severe cardiovascular disease or diabetes.
4. Recent Participation: Involvement in other clinical trials within the past 30 days.
5. Psychiatric Disorders: Severe psychiatric conditions that could interfere with the study.

MEDICATIONS:

Participants will be administered specific medications and treatments including:

1. Dopamine Agonists: Medications that mimic the effect of dopamine in the brain.
2. MAO-B Inhibitors: Drugs that prevent the breakdown of brain dopamine.
3. Investigational Drugs: New treatments being tested for efficacy and safety.
4. Adjunct Therapies: Supportive treatments such as physical therapy and dietary interventions.

This research aims to improve the quality of life and outcomes for individuals with Parkinson’s disease.